Research and Markets: Abilify (Aripiprazole) Major Depressive Disorder Drug …
Abilify (aripiprazole) is an atypical antipsychotic indicated for use as an adjunctive treatment for MDD in patients who have not adequately responded to antidepressant therapy in the US. Abilify is available in the 5EU, Japan, and Australia, but is …
Read more on Business Wire (press release)
Research and Markets: Euthymics Bioscience's Amitifadine (Major Depressive …
Overview of Major depressive disorder, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on Amitifadine including product description …
Read more on Business Wire (press release)
Latest Major Depressive Disorder News
No comments:
Post a Comment